HealthCareTips blog

AstraZeneca to discontinue Epanova trial, expects $100 million writedown

AstraZeneca to discontinue Epanova trial, expects $100 million writedown
Reuters: Health
AstraZeneca said on Monday it will discontinue a late-stage trial for Epanova to treat patients with mixed dyslipidaemia at high risk of cardiovascular disease and expects a $100 million writedown to hit its core profit in the fourth quarter.

Switzerland's Obseva eyes China re-start for fertility drug that failed trial

Switzerland's Obseva eyes China re-start for fertility drug that failed trial
Reuters: Health
ObsEva struck a pact with China's Yuyuan BioScience Technology to develop and commercialize the fertility drug nolasiban, the Swiss drugmaker said on Monday as it seeks to inject new life into a medicine that had flopped a trial.

China pneumonia outbreak not spreading at present: WHO

China pneumonia outbreak not spreading at present: WHO
Reuters: Health
An outbreak of pneumonia that has killed one person in China and infected 40 others appears to be linked to a single seafood market in the central city of Wuhan and has not spread beyond there so far, the World Health Organization said on Sunday.

China virus outbreak linked to seafood market not currently spreading: WHO

China virus outbreak linked to seafood market not currently spreading: WHO
Reuters: Health
An outbreak of pneumonia that has killed one person in China and infected 40 others appears to be linked to a single seafood market in the central city of Wuhan and has not so far spread beyond there, the World Health Organization said on Sunday.